Noradrenergic and serotonergic mediation of spinal analgesia mechanisms.
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D003000:Clonidine / Q000494:pharmacology; D002818:Cordotomy; D005260:Female; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D009433:Neural Inhibition; D018377:Neurotransmitter Agents / Q000378:metabolism; D009638:Norepinephrine / Q000032:analysis / Q000494:pharmacology; D011814:Quipazine / Q000494:pharmacology; D051381:Rats; D011930:Reaction Time; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects*; D011985:Receptors, Serotonin / Q000187:drug effects*; D012701:Serotonin / Q000032:analysis / Q000494:pharmacology; D013116:Spinal Cord / Q000187:drug effects* / Q000502:physiology; D013566:Sympathomimetics / Q000494:pharmacology; D013997:Time Factors; D014991:Xylazine / Q000494:pharmacology
D000700:Analgesics; D006993:Hypnotics and Sedatives; D018377:Neurotransmitter Agents; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D011985:Receptors, Serotonin; D013566:Sympathomimetics; D014991:Xylazine; D012701:Serotonin; D011814:Quipazine; D003000:Clonidine; D009638:Norepinephrine